share_log

Shareholder Alert: Ademi LLP Investigates Whether Deciphera Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With ONO Pharmaceutical Co.

Shareholder Alert: Ademi LLP Investigates Whether Deciphera Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With ONO Pharmaceutical Co.

股东提醒:Ademi LLP正在调查Deciphera Pharmaceuticals, Inc. 在与小野制药公司的交易中是否获得了公平的价格。
PR Newswire ·  04/29 10:30

MILWAUKEE, April 29, 2024 /PRNewswire/ -- Ademi LLP is investigating Deciphera (NASDAQ: DCPH) for possible breaches of fiduciary duty and other violations of law in its transaction with ONO.

密尔沃基,2024年4月29日 /PRNewswire/ — Ademi LLP正在调查Deciphera(纳斯达克股票代码:DCPH)在与ONO的交易中可能违反信托义务和其他违法行为

Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

点击此处了解如何加入或拨打 Guri Ademi 的免费电话 866-264-3995。您无需支付任何费用或承担任何义务。

In the transaction, Deciphera stockholders will receive only $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of ONO, for a total equity value of $2.4 billion. The transaction agreement unreasonably limits competing transactions for Deciphera by imposing a significant penalty if Deciphera accepts a competing bid. Deciphera insiders will receive substantial benefits as part of change of control arrangements.

在这笔交易中,Deciphera的股东将通过要约获得每股25.60美元的现金,随后Deciphera与ONO的全资子公司合并,总股权价值为24亿美元。该交易协议不合理地限制了Deciphera的竞争交易,如果Deciphera接受竞争性出价,将处以巨额罚款。作为控制权变更安排的一部分,Deciphera内部人士将获得可观的收益。

We are investigating the conduct of Deciphera's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

我们正在调查Deciphera董事会的行为,以及他们是否履行了对所有股东的信托责任。

If you own Deciphera common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or

如果你拥有Deciphera普通股并希望获得更多信息,请致电 [email protected] 或免费电话:866-264-3995 与 Guri Ademi 联系,或

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

我们专门处理涉及收购、合并和全国各地个人股东权利的股东诉讼。欲了解更多信息,请随时致电我们。律师广告。先前的结果并不能保证类似的结果。

Contacts

联系人

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Ademi LLP
Guri Ademi
免费电话:(866) 264-3995
传真:(414) 482-8001

SOURCE Ademi LLP

来源 Ademi LLP

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发